Spatial patterns show how dose changes across anatomical locations rather than treating the dose as a single overall value. Examining these changes reveals whether higher-dose regions align with the intended target and whether dose extends into nearby healthy structures. This supports a more detailed assessment of treatment quality than a single summary dose value.
Dose gradients describe how rapidly dose values change across neighboring regions. A steep or broad change can indicate how treatment coverage transitions near the target and how exposure reaches surrounding tissues. Reviewing these gradients helps clinicians interpret the spatial relationship between therapeutic dose regions and areas where limiting normal-tissue exposure is important.
A dose-volume relationship connects dose values with the amount of tissue receiving them. This perspective helps distinguish a localized high-dose region from broader exposure affecting a larger tissue volume. Used alongside anatomical location, it provides complementary information for evaluating target coverage and normal-tissue exposure during medical treatment assessment.
The analysis can place calculated or planned dose information alongside measured or delivered dose information. Comparing the two distributions helps identify whether the treatment received follows the expected spatial pattern and dose-volume relationship. This comparison is useful for recognizing differences that may affect interpretation of therapeutic coverage or exposure to healthy structures.
Assessment uses dose values linked to anatomical location or tissue volume. The information may come from calculated data, measured data, or both, depending on the purpose of the evaluation. Organizing dose in these ways allows reviewers to examine spatial patterns, dose gradients, and dose-volume relationships rather than relying on uncontextualized dose values.
In radiation-based care, clinicians use the analysis during treatment planning to examine whether the proposed dose distribution supports the intended therapeutic coverage while limiting exposure to healthy structures. It also contributes to quality assurance and later comparison of delivered with intended distributions, making it relevant both before treatment and during evaluation of treatment performance.
Treatment planning benefits from viewing dose in relation to the target and surrounding anatomy. This examination can show whether the planned distribution places dose where intended and how exposure patterns extend beyond the target region. The resulting information helps clinicians evaluate therapeutic coverage together with normal-tissue exposure when reviewing or comparing treatment plans.
Clinicians can interpret whether the target region receives the intended dose pattern, whether dose gradients occur in expected anatomical locations, and whether healthy structures experience substantial exposure. When calculated and measured or delivered distributions are compared, the analysis also indicates how closely treatment performance matches the intended plan, supporting quality assurance and clinical review.